Tema Heart & Health ETF (HRTS)
NASDAQ: HRTS · Real-Time Price · USD
36.28
+0.53 (1.47%)
Jan 21, 2026, 4:00 PM EST - Market closed
HRTS Holdings Information
HRTS is an equity ETF with a total of 46 individual holdings. The top holdings are Eli Lilly and Company stock at 10.27%, Roche Holding AG at 5.18%, UnitedHealth Group at 4.60%, Johnson & Johnson at 4.42%, and AstraZeneca at 4.32%.
Total Holdings
46
Top 10 Percentage
47.58%
Asset Class
Equity
ETF Category
Health
Assets
56.90M
PE Ratio
23.50
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 10.27% |
| 2 | RHHBY | Roche Holding AG | 5.18% |
| 3 | UNH | UnitedHealth Group Incorporated | 4.60% |
| 4 | JNJ | Johnson & Johnson | 4.42% |
| 5 | LON: AZN | AstraZeneca PLC | 4.32% |
| 6 | TMO | Thermo Fisher Scientific Inc. | 4.22% |
| 7 | MRK | Merck & Co., Inc. | 4.14% |
| 8 | ABT | Abbott Laboratories | 3.64% |
| 9 | CPH: NOVO.B | Novo Nordisk A/S | 3.62% |
| 10 | SWX: NOVN | Novartis AG | 3.19% |
| 11 | GILD | Gilead Sciences, Inc. | 3.12% |
| 12 | BSX | Boston Scientific Corporation | 3.03% |
| 13 | MDT | Medtronic plc | 2.97% |
| 14 | ABBV | AbbVie Inc. | 2.83% |
| 15 | DHR | Danaher Corporation | 2.78% |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 2.72% |
| 17 | BBIO | BridgeBio Pharma, Inc. | 2.32% |
| 18 | RVMD | Revolution Medicines, Inc. | 2.31% |
| 19 | AMGN | Amgen Inc. | 2.09% |
| 20 | REGN | Regeneron Pharmaceuticals, Inc. | 1.96% |
| 21 | BMY | Bristol-Myers Squibb Company | 1.95% |
| 22 | MCK | McKesson Corporation | 1.86% |
| 23 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 1.66% |
| 24 | ISRG | Intuitive Surgical, Inc. | 1.59% |
| 25 | EW | Edwards Lifesciences Corporation | 1.58% |
As of Jan 16, 2026